Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

In August, the U.S. Food and Drug Administration approved the new COVID-19 booster shots, but with certain restrictions.

A U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on Friday to review data on the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, with a vote expected on ...

US court orders Pfizer and FDA to disclose COVID-19 vaccine side effect data decades ahead, revealing thousands of adverse events across body systems.

Nine leading U.S. and European vaccine developers pledged on Tuesday to uphold the scientific standards their experimental immunisations will be held against in the global race to contain the ...

Prices for many prescription drugs would drop significantly under an agreement announced Tuesday by the Trump administration and drugmaker Pfizer. "As you know, the United States is paying sometimes ...

Sen. Ruben Gallego (D-Ariz.) is raising concerns over the lack of details given about President Trump’s “most favored nation” (MFN) pricing deal he announced with Pfizer this week, calling on the ...

Against a backdrop of tariff updates and a drug pricing deal from the Trump administration, the FDA charted a pair of moves this week in its push to make drug manufacturing more attractive in the U.S.

WASHINGTON — President Donald Trump and drug manufacturer Pfizer announced a deal Tuesday to lower certain drug prices. The arrangement would bring American drug prices in line with the lowest paid by ...

Pfizer’s revenue soared in early pandemic days thanks to its coronavirus products -- but demand for them has since slipped. The company has taken steps to boost growth in the coming years and just ...

Nikki Battiste is a CBS News national correspondent based in New York. She is an Emmy and Peabody-award winning journalist, and her reporting appears across all CBS News broadcasts and platforms.

Over a weekend in late September, the team of Pfizer PFE-0.04%decrease; red down pointing triangle officials working with the Trump administration on drug prices got a message: Clear your schedules.